2010/10/31
BDA advises Trivium Technologies on sale of the Brilliant Film IP portfolio to N&F, Korea
Divested Brilliam Film IP portfolio N&F, Korea
2010
Business Development Asia LLC (“BDA”) has advised Trivium Technologies (“Trivium”), a Cleveland, Ohio-based display technology company, on the sale of its intellectual property (“IP”) portfolio of BRILLIANT Film, the company’s brightness enhancement film, to Nature & Future (“N&F”), a Korean LCD display component company.
N&F acquired a broad global technology IP portfolio from Trivium that includes brightness enhancement film technology and solar concentrator technology. This acquisition will allow N&F to enter the Korean LCD optical film market with patent-protected multifunction films that deliver enhanced performance at competitive prices.
To date, the optical film market has been dominated by large multinational companies such as 3M. IP protected technology is always a high entry barrier to new market entrants. Recognizing the importance of IP, N&F believes this acquisition will be a significant stepping stone in penetrating the low and high-end optical film markets without the risk of patent infringement.
Trivium has developed an extensive IP portfolio for light management films. With the LCD industry concentrated primarily in Korea, Trivium believes this transaction can ideally combine US technology and Asian manufacturing expertise. Trivium’s management will continue to work with N&F on the commercialization of these technologies.
Tom Lash, Trivium’s Chief Operating Officer, stated that “BDA provided a comprehensive effort to ensure that the N&F acquisition was successfully completed. The BDA team, led in Korea by Mr. Heejun Yang, was persistent in their guidance, due diligence and negotiation efforts. They certainly exceeded our expectations.”
BDA Deal Team:
Euan Rellie, Senior Managing Director
Heejun Yang, Assistant Director
Jay Shin, Senior Associate
About Trivium Technologies:
Trivium Technologies, Inc., formed in 2000 and based in Cleveland, Ohio, has developed the next-generation brightness optimization films for LCD displays. Trivium’s BRILLIANT Film utilizes an innovative design of embedded light-guiding structures and a recycling layer within a single film that improves the display’s brightness. Trivium has a globally-filed robust IP Patent portfolio that includes a family of light management films. In addition to the BRILLIANT Film, Trivium also has preliminary design patents for light management films for transflective and OLED displays, and solar concentrator films.
About Business Development Asia
Business Development Asia LLC (“BDA”) assists multinational corporate and financial sector clients to identify and execute acquisitions, divestments, JVs, restructuring and capital raising, in Asia and internationally. The company is headquartered in New York with offices in London, Bahrain, Mumbai, Hong Kong, Shanghai, Seoul, and Tokyo. BDA employs 60 full-time professionals across its eight offices, supplemented by a team of senior advisors around the world. BDA’s clients include Air Products, Areva, AXA PE, Cadbury Schweppes, Celestica, Clariant, Cookson, DIC, DuPont, Ecolab, Godrej, Hanjin, Henkel, Hercules, Huntsman, Kennametal, Kimberly-Clark, Lear, Lubrizol, Mars, Molex, Nalco, Pfizer, Rexel, Reuters, Rohm & Haas, Ryder, Siemens, SigmaKalon, Sumitomo Chemical, Sun Chemical, Tata, Tenneco, Tredegar, Visteon, Weir, WestLB, WR Grace, and the British Government. www.bdapartners.com
For more information regarding this transaction, please contact Heejun Yang in Seoul on (82) 2 767 2730 or Euan Rellie in New York on (1) 212 265 5300
Recent transactions
and other shareholders divested a controlling stake in
to
2025
acquired 75% stake in
2024
invested in
2024
divested BusinessOn to
2024
raised growth capital from a consortium led by
2024
acquired majority stake in
2024
acquired 70% of
2023
a portfolio company of
has been acquired by
2023
divested Wavedash to
2023
has been acquired by
2023
has been acquired by
2022
series D capital raise from
2022
a portfolio company of
has acquired
2022
series A capital raise from
RMB investors, including Tianjin Bohai Fund
2022
series C capital raise from
2022
has been acquired by
2022
divested stake in
to
2021
has been acquired by
2021
invested $150m in
2021
series D capital raise led by
2021